Edwards Lifesciences's total assets for Q2 2025 were $13.49B, an increase of 3.58% from the previous quarter. EW total liabilities were $2.88B for the fiscal quarter, a 1.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.